Nephrology Flashcards
The prevalence of diabetic nephropathy in Type 1 diabetes mellitus:
A) below 5%
B) 20–30%
C) 80–90%
D) it develops in all patients
B) 20–30%
In diabetic patients treated with metformin, metformin should not be administered prior to any scheduled examination using contrast agent if eGFR <30 ml/min/1,73m2:
A) administration should be continued
B) administration should be suspended only on the day of the examination
C) administration should be suspended by two days prior to the examination
D) administration should be suspended by one week prior to the examination
C) administration should be suspended by two days prior to the examination
The most important factor in the early diagnosis of diabetic nephropathy:
A) the appearance of hypertension
B) the appearance of microalbuminuria
C) the increase of serum creatinine level
D) the decrease of eGFR
B) the appearance of microalbuminuria
Diabetic nephropathy is reversible:
A) even if eGFR is reduced
B) in the stage of macroalbuminuria
C) in the stage of microalbuminuria
D) even if the serum creatinine is increased
C) in the stage of microalbuminuria
It is fundamental in the treatment of diabetic nephropathy to give:
A) renin–angiotensin–aldosterone system (RAAS) inhibitors
B) alpha-blockers
C) high-dose thiazide diuretics
D) direct vasodilator antihypertensives
A) renin–angiotensin–aldosterone system (RAAS) inhibitors
The progression of diabetic nephropathy may be accelerated by:
A) euglycaemia
B) increased protein intake
C) reduced salt intake
D) antihypertensive therapy
B) increased protein intake
In diabetic patients treated with metformin, metformin therapy can be continued after the contrast agent examination:
A) on the day of the examination
B) on the next day, irrespective of renal function
C) 48 hours after the examination, if GFR is below 30 ml/min/1,73m2
D) 48 hours after the examination, if GFR is above 30 ml/min/1,73m2
D) 48 hours after the examination, if GFR is above 30 ml/min/1,73m2
Patients with Type 1 diabetes have to be screened for diabetic nephropathy:
A) upon establishing the diagnosis
B) approx. 5 years after the diagnosis was established
C) approx. 10-15 years after the diagnosis was established
D) approx. 20-30 years after the diagnosis was established
B) approx. 5 years after the diagnosis was established
Patients with Type 2 diabetes have to be screened for diabetic nephropathy:
A) upon establishing the diagnosis
B) approx. 5 years after the diagnosis was established
C) approx. 10-15 years after the diagnosis was established
D) approx. 20-30 years after the diagnosis was established
A) upon establishing the diagnosis
Diabetic nephropathy is likely to have developed in a diabetic patient with proteinuria
A) in the absence of diabetic retinopathy
B) if the patient has diabetic retinopathy but no haematuria
C) if the patient has diabetic retinopathy and haematuria
D) it is likely in all the above cases
B) if the patient has diabetic retinopathy but no haematuria
Metformin is contraindicated in diabetic patients:
A) if the eGFR is below 30 ml/min
B) if the patient is obese
C) if the patient has hypertension
D) if the patient has thyroid disease
A) if the eGFR is below 30 ml/min
Nephrotic syndrome is defined as:
A) significant proteinuria
B) hypalbuminaemia
C) predisposition to oedema
D) the concurrent presence of all three factors above
D) the concurrent presence of all three factors above
In case of the presence of glomerular type red blood cells in the urine sediment:
A) renal stone is suspected, the patient should be referred first to urology examination
B) tumour is suspected, the patient should be referred first to urology examination
C) glomerular disease is suspected, the patient should be referred first to nephrology examination
D) uroinfection is suspected, the patient should be referred first to urology examination
C) glomerular disease is suspected, the patient should be referred first to nephrology examination
Analgesic nephropathy:
A) is an acute kidney injury caused by NSAIDs
B) is a chronic kidney disease caused by NSAIDs
C) is a glomerulonephritis caused by NSAIDs
D) is an acute kidney injury caused by steroidal anti-inflammatory drugs
B) is a chronic kidney disease caused by NSAIDs
Risk factors for acute kidney injury exclude:
A) old age
B) intravenous contrast agents
C) NSAIDs abuse
D) increased fluid intake
D) increased fluid intake
In acute kidney injury, renal cause may be suspected in the case of:
A) isolated or marked increase of the serum carbamide nitrogen level
B) bladder retention
C) marked increase of the serum creatinine level in conjunction with less marked increase of the serum carbamide nitrogen level
D) decreased turgor of the skin and dry tongue
C) marked increase of the serum creatinine level in conjunction with less marked increase of the serum carbamide nitrogen level
In the case of acute kidney injury and glomerular haematuria or the presence of RBC cylinders in the urine:
A) pre-renal causes should be searched
B) renal cause, e.g. acute glomerulonephritis is suspected
C) post-renal cause should be searched
B) renal cause, e.g. acute glomerulonephritis is suspected
The most common cause of acute kidney injury out of the following:
A) pre-renal causes
B) renal causes
C) post-renal causes
A) pre-renal causes
The most common causes of primary nephrotic syndrome:
1) membranous glomerulonephritis
2) minimal change disease
3) focal segmental glomerulosclerosis
4) IgA nephropathy
A) answers 1., 2. and 3. are correct
B) answers 1. and 3. are correct
C) answers 2. and 4. are correct
D) only answer 4. is correct
E) all 4 answers are correct
A) answers 1., 2. and 3. are correct
In the case of glomerular type haematuria after respiratory infection the following pathology/pathologies may be suspected:
1) minimal change disease
2) IgA nephropathy
3) membranous glomerulonephritis
4) acute, post-streptococcal glomerulonephritis
A) answers 1., 2. and 3. are correct
B) answers 1. and 3. are correct
C) answers 2. and 4. are correct
D) only answer 4. is correct
E) all 4 answers are correct
C) answers 2. and 4. are correct
If RAAS-inhibitor therapy was commenced for treating diabetic nephropathy, after the initiation, the following should be controlled:
1) serumcreatinine and eGFR
2) blood lipids
3) serum potassium level
4) RBC sedimentation rate
A) answers 1., 2. and 3. are correct
B) answers 1. and 3. are correct
C) answers 2. and 4. are correct
D) only answer 4. is correct
E) all 4 answers are correct
B) answers 1. and 3. are correct